CPT2 and ataxia telangiectasia: In contrast, carnitine-acylcarnitine translocase (CACT) and carnitine palmitoyltransferase (CPT2) showed a significantly 1.2–1.3 fold higher mRNA expression in AT patients when compared to the control subjects (Fig 2, S2 Table).